FindTrial
Sign In

Management Of Tinea Corporis In Farmers By Homoeopathic Medicines

To Study Efficacy Of Individualised Homoeopathic Medicines In Cases Of Tinea Corporis In Farmers By Using mTCS :A Single Blind, Randomized, Placebo Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098533
Enrollment
50
Registered
2025-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Individualised Homeopathic Medicine: Selection of Individualised Homeopathic Medicine on Based of symptom totality of Patients.potency and repetation of medicine is based of patient con

Sponsors

Jawaharlal Nehru Homeopathic Medical Collage And Hospital,Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A. Farmers who Clinically diagnosed with Tinea Corporis . B. Patients who are Willing to give informed consent.

Exclusion criteria

Exclusion criteria: A. Patient taking other mode of treatment for Tinea Corporis. B. Patients with Secondary infection.

Design outcomes

Primary

MeasureTime frame
To study the efficacy of individualized homeopathic medicines compared to placebo in cases of tinea corporis among farmers.Timepoint: 6 months—

Secondary

MeasureTime frame
1.To Assess the Severity & Outcome of Patients before & after treatment in cases of Tinea Corporis. 2.To Assess the Outcome Within 3 months of intervention by using Modified Tinea Corporis Scale. 3.To observe the effect of individualized homeopathic medicines in cases of tinea corporis among farmers.Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Yashkumar Jagdishbhai Makvana

Jawaharlal Nehru Homeopathic Medical Collage And Hospital

kirtida.desai@paruluniversity.ac.in9574424363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026